sch 40120 has been researched along with Psoriasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blumenkrantz, N; Cayen, MN; Chan, TM; Du, Y; Friary, R; Laudicina, D; McPhail, AT; Ng, K; Patrick, JE; Pramanik, B; Seidl, V; Shannon, D; Spangler, M; Thonoor, CM; Zbaida, S | 1 |
1 other study(ies) available for sch 40120 and Psoriasis
Article | Year |
---|---|
In vitro metabolism of 10-(3-chlorophenyl)-6,8,9,10-tetrahydrobenzo[b][1,8]naphthyridin-5(7H)- one, a topical antipsoriatic agent. Use of precision-cut rat, dog, monkey and human liver slices, and chemical synthesis of metabolites.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Dogs; Humans; Hydroxylation; In Vitro Techniques; Liver; Macaca fascicularis; Male; Naphthyridines; Psoriasis; Rats; Rats, Sprague-Dawley; Species Specificity | 1998 |